Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer bij ACOTEC SCIENTIFIC HOLDINGS LIMITED
Profiel
Ulrich Reinhold Speck is the founder of InnoRa GmbH, which was founded in 2001.
He held the title of Managing Director & Legal Representative from 2001 to 2017.
Currently, he is the Chief Technology Officer at Acotec Scientific Holdings Ltd.
since 2021.
Previously, he worked as a Professor at Charité - Universitätsmedizin Berlin from 2000 to 2001.
Dr. Speck received his doctorate degree from Freie Universität Berlin in 1967.
Actieve functies van Ulrich Reinhold Speck
Bedrijven | Functie | Begin |
---|---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29-01-2021 |
Eerdere bekende functies van Ulrich Reinhold Speck
Bedrijven | Functie | Einde |
---|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 18-01-2017 |
Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01-01-2001 |
Opleiding van Ulrich Reinhold Speck
Freie Universität Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |